Loading...
Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma
The fibroblast growth factor (FGF) signaling cascade is a key signaling pathway in hepatocarcinogenesis. We report high FGF receptor (FGFR) expression in 17.7% (11 of 62) of hepatocellular carcinoma (HCC) models. Infigratinib, a pan‐FGFR inhibitor, potently suppresses the growth of high‐FGFR‐express...
Na minha lista:
| Udgivet i: | Hepatology |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6635738/ https://ncbi.nlm.nih.gov/pubmed/30575985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30481 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|